China Pharma Holding (STU:XQJ0) Scaled Net Operating Assets : 0.68 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

China Pharma Holding's operating assets for the quarter that ended in Dec. 2023 was €13.80 Mil. China Pharma Holding's operating liabilities for the quarter that ended in Dec. 2023 was €4.02 Mil. China Pharma Holding's Total Assets for the quarter that ended in Sep. 2023 was €14.39 Mil. Therefore, China Pharma Holding's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.68.

China Pharma Holding Scaled Net Operating Assets Historical Data

The historical data trend for China Pharma Holding's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Scaled Net Operating Assets Chart

China Pharma Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.33

0.60

0.70

0.52

0.58

China Pharma Holding Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.64	0.68	0.64	0.66	0.68

Competitive Comparison of China Pharma Holding's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Pharma Holding's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's Scaled Net Operating Assets falls into.

China Pharma Holding Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

China Pharma Holding's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(13.796	-	4.018)	/	16.788
=	0.58

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	15.102	-	1.306
=	13.796

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.267	-	1.331	-	2.918
=	4.018

China Pharma Holding's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Sep. 2023 )
=	(13.796	-	4.018)	/	14.385
=	0.68

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	15.102	-	1.306
=	13.796

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.267	-	1.331	-	2.918
=	4.018

China Pharma Holding Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

China Pharma Holding (STU:XQJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

CPHI:USA

Address

Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216

Website

https://www.chinapharmaholdings.com

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines